Literature DB >> 9701000

Review article: Long-term Helicobacter pylori infection--from gastritis to gastric cancer.

M Asaka1, M Kudo, M Kato, T Sugiyama, H Takeda.   

Abstract

An analysis carried out in 1994 by the WHO International Agency for Research on Cancer (IARC) resulted in Helicobacter pylori being designated as a Group 1 carcinogen and thus clearly having an association with the development of gastric cancer. In the case of H. pylori, the evaluation was made solely on the basis of epidemiological results. In Japan, in 1993, only 235,000 of the 60 million people with H. pylori had gastric cancer. This represents only 0.4% of the infected population. Each individual reacts in a unique way to H. pylori infection in terms of the inflammatory response. The probability of developing cancer will be determined by environmental factors such as diet, duration of or age at acquisition of H. pylori infection, the virulence of H. pylori strains, and host factors including genetic make-up.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9701000     DOI: 10.1111/j.1365-2036.1998.00007.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  12 in total

1.  The Helicobacter pylori CrdRS two-component regulation system (HP1364/HP1365) is required for copper-mediated induction of the copper resistance determinant CrdA.

Authors:  Barbara Waidner; Klaus Melchers; Frank Nils Stähler; Manfred Kist; Stefan Bereswill
Journal:  J Bacteriol       Date:  2005-07       Impact factor: 3.490

2.  Who's Winning the War? Molecular Mechanisms of Antibiotic Resistance in Helicobacter pylori.

Authors:  Kathleen R Jones; Jeong-Heon Cha; D Scott Merrell
Journal:  Curr Drug ther       Date:  2008-09-01

3.  Antibody response of patients with Helicobacter pylori-related gastric adenocarcinoma: significance of anti-cagA antibodies.

Authors:  C Vaucher; B Janvier; J B Nousbaum; B Grignon; L Pezennec; M Robaszkiewicz; H Gouerou; B Picard; J L Fauchere
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

4.  Identification by RNA profiling and mutational analysis of the novel copper resistance determinants CrdA (HP1326), CrdB (HP1327), and CzcB (HP1328) in Helicobacter pylori.

Authors:  Barbara Waidner; Klaus Melchers; Igor Ivanov; Hannes Loferer; Klaus W Bensch; Manfred Kist; Stefan Bereswill
Journal:  J Bacteriol       Date:  2002-12       Impact factor: 3.490

5.  Bile acid reflux and possible inhibition of Helicobacter pylori infection in subjects without gastric surgery.

Authors:  Y Kawai; S Tazuma; M Inoue
Journal:  Dig Dis Sci       Date:  2001-08       Impact factor: 3.199

Review 6.  Gastrin - active participant or bystander in gastric carcinogenesis?

Authors:  Susan A Watson; Anna M Grabowska; Mohamad El-Zaatari; Arjun Takhar
Journal:  Nat Rev Cancer       Date:  2006-12       Impact factor: 60.716

Review 7.  Eradication of Helicobacter pylori for primary gastric cancer and secondary gastric cancer after endoscopic mucosal resection.

Authors:  Motosugu Kato; Masahiro Asaka; Shouko Ono; Manabu Nakagawa; Souichi Nakagawa; Yuichi Shimizu; Makoto Chuma; Hiroshi Kawakami; Yoshito Komatsu; Shuhei Hige; Hiroshi Takeda
Journal:  J Gastroenterol       Date:  2007-01       Impact factor: 7.527

8.  Identification and characterization of novel Helicobacter pylori apo-fur-regulated target genes.

Authors:  Beth M Carpenter; Jeremy J Gilbreath; Oscar Q Pich; Ann M McKelvey; Ernest L Maynard; Zhao-Zhang Li; D Scott Merrell
Journal:  J Bacteriol       Date:  2013-10-04       Impact factor: 3.490

9.  A study of Helicobacter pylori-associated gastritis patterns in Iraq and their association with strain virulence.

Authors:  Nawfal R Hussein; Sarbar M Napaki; John C Atherton
Journal:  Saudi J Gastroenterol       Date:  2009-04       Impact factor: 2.485

10.  Essential role of ferritin Pfr in Helicobacter pylori iron metabolism and gastric colonization.

Authors:  Barbara Waidner; Stefan Greiner; Stefan Odenbreit; Holger Kavermann; Jyoti Velayudhan; Frank Stähler; Johannes Guhl; Emmanuel Bissé; Arnoud H M van Vliet; Simon C Andrews; Johannes G Kusters; David J Kelly; Rainer Haas; Manfred Kist; Stefan Bereswill
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.